Pharmacy Podcast Network

Επεισόδια

• 
  The NACDS Total Store Expo Rewind | Part Two 16.09.2026 51λ

  The NACDS Total Store Expo was in Boston, MA from August 15-17! Pharmacy owners, pharmacy students, and pharmacists gathered for forward thinking conversations and innovation to create more profit and better outcomes in their pharmacies. The NACDS TOTAL STORE EXPO is the largest gathering of retailers and suppliers in the health and wellness industry. Discover new and innovative products, technology and services and find the partners you need to thrive in an unpredictable consumer environment.   In this "on the street" style of interviews, our host Todd Eury, CEO and Founder of the Pharmacy Podcast Network connects with:   Stephen Beckman - YARAL Pharma Marzio Pozzuoli - NuraLogix Rob Headman - First Data Bank Justin Hammerling - Infinitrak Matt Gilbert - Medsense Anthony Dragisics - ELOS Thermal Richard Voskoboynikov - Wolters Kluwer Chris Krese - NACDS 
• 
  Following the Patient Instead of the Paradigm with Dr. Pamela M. Cipriano | The Holistic Pharmacy Podcast 15.09.2026 1ώ 6λ

  I felt like I could record a whole series of episodes, and still not run out of topics to talk about with today’s guest, and glean her wisdom. Her own story and the health challenges of her loved ones have inspired her to become the kind of practitioner she sought. She and I agree: true healing is about supporting the body's innate ability to recover. Coming from a conventional emergency-care background, she’s built a successful concierge practice showcasing that personalized nutrition, targeted supplementation, and addressing the root causes of illness helps patients achieve lasting wellness.Dr. Pamela M. Cipriano, DNP, APRN, ACNP-BC, is the founder and president of The Practice of Health and Wellness in Thomaston, Connecticut. A board-certified Acute Care Nurse Practitioner with more than 30 years of healthcare experience, she specializes in integrative and functional medicine, helping patients with complex chronic illnesses by combining evidence-informed conventional care with personalized, root-cause approaches.Dr. Cipriano is an international speaker, published researcher, and member of the ILADS (International Lyme and Associated Diseases Society) Membership Committee. She is passionate about educating both patients and healthcare professionals on the interconnected roles of immune dysfunction, chronic infections, nutrition, environmental health, and lifestyle in achieving lasting wellness and restoring hope for those living with complex chronic disease.Connect with Dr. Pamela via:Email: [email protected]: thepracticeofhealthandwellness.comFB: https://www.facebook.com/dr.pamela.ciprianoIG: https://www.instagram.com/practicehealthwellnessYT: https://www.youtube.com/@dr.pamelacipriano1329LI: linkedin.com/in/dr-pamela-m-cipriano-dnp-aprn-673a2224
• 
  Specialty Pharmacy Access, Innovation & Independent Pharmacy Growth | TWIRx 11.09.2026 58λ

  Specialty Pharmacy Access, Innovation & Independent Pharmacy Growth   This Week in Pharmacy, we explore specialty pharmacy, pharmacy innovation, emerging career opportunities, and new business models for independent community pharmacy.   Today’s episode is sponsored by Clearway Health, Value Drug Company, and FDB (First Databank, Inc.)   First, Allison Arant of Clearway Health joins us to discuss the next phase of specialty pharmacy within hospitals and health systems.   As rare disease and specialty therapies become more complex, health systems are looking for better ways to improve medication access, strengthen continuity of care, and keep patients connected to trusted clinical teams.   Todd and Allison discuss how health-system specialty pharmacy can expand community access and improve management of complex and rare disease treatments.   Learn more: https://www.clearwayhealth.com/   National Association of Specialty Pharmacy (NASP) #inSPire2026   Next, we preview inSPire 2026, taking place September 22–25, 2026, at the Gaylord National Resort & Convention Center in National Harbor, Maryland.   The specialty pharmacy community will come together to discuss medication access, emerging therapies, technology, patient services, clinical care, and the continued evolution of specialty pharmacy.   The Next Dose Summit   Then we welcome Jordan Smith, PharmD, AAHIVP, CPGx, and Melinda Fowler, RPh, ABAAHP, FAAFM to preview The Next Dose Summit, happening October 14–15, 2026.   RxPR and the Pharmacy Podcast Network are proud press and media partners.   The event focuses on innovation, entrepreneurship, leadership, emerging career pathways, and new opportunities for pharmacists looking beyond traditional roles.   It is designed for pharmacists, students, entrepreneurs, and healthcare leaders asking one important question:   What’s next for pharmacy — and what’s next for me?   Register here: https://www.jscommunitycare.org/store/p/2026-the-next-dose-summit-registration   Expanding Independent Pharmacy   Finally, Rick Seipp, PharmD, President and CEO of Value Drug Company, returns to discuss creative strategies for expanding independent community pharmacy.   Todd and Rick explore cash-based pharmacy, transparent pricing, clinical services, new revenue streams, and other non-PBM-dependent models that can help independent pharmacies diversify and grow.   The conversation focuses on how community pharmacies can strengthen their businesses while continuing to serve as trusted healthcare destinations.   Learn more: https://www.valuedrugco.com/   Sponsored By   Clearway Health https://www.clearwayhealth.com/   Value Drug Company https://www.valuedrugco.com/   First Databank — FDB https://www.fdbhealth.com/   TWIRx — This Week in Pharmacy is hosted by Todd S. Eury and produced by the Pharmacy Podcast Network — Amplifying the Voice of Pharmacists & Our Profession.
• 
  Reputation in a Digital Age: Building Trust Online for Pharmacies | Marketing Vitals 10.09.2026 29λ

  A strong online reputation starts with meaningful patient experiences. Join us as we explore how pharmacies can build trust, engage with their communities online, and manage their digital presence. Featuring special guest and trusted partner FlavoRx, who shares industry insights on creating positive patient experiences that inspire lasting loyalty—both in the pharmacy and online.
• 
  The NACDS Total Store Expo Rewind | Part One 09.09.2026 50λ

  Thank you First Data Bank (FDB) for sponsoring this episode's coverage of the NACDS Total Store Expo! The NACDS Total Store Expo was in Boston, MA from August 15-17! Pharmacy owners, pharmacy students, and pharmacists gathered for forward thinking conversations and innovation to create more profit and better outcomes in their pharmacies. The NACDS TOTAL STORE EXPO is the largest gathering of retailers and suppliers in the health and wellness industry. Discover new and innovative products, technology and services and find the partners you need to thrive in an unpredictable consumer environment. In this "on the street" style of interviews, our host Todd Eury, CEO and Founder of the Pharmacy Podcast Network connects with: Mike Plinski - FDB (First Data Bank) Amantha Bagdon - RxPost Kris Rhea - Pharmacy Marketplace EJ George - Pharmacy Student Christopher Thomsen - CAPSA Healthcare Heather Haro - DiversifyRx Daniel Heusmann - Eyecon RxSafe
• 
  Grief and Relationships | Sex PharmD 08.09.2026 31λ

  This episode explores how to navigate grief and how it can impact relationships including the one with yourself. Link to Hope Edelman's book "Motherless Daughters" https://www.hopeedelman.com/books Link to Emma Hemming Willis' book "The Unexpected Journey" https://emmahemingwillis.com/the-unexpected-journey/Link to Rx Meter Product Sleep Spray: https://myplusone.com/products/restful-sleep-magnesium-spray   TzrIckmic7Yeigg0uagt
• 
  From Access to Outcomes: The Changing Role of HUBs | NASP Specialty Pharmacy Podcast 07.09.2026 24λ

  On this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Narlyn Lopes and Megan Winebrenner of CenterWell Specialty Pharmacy to talk about how modern hub models have grown well past basic access support; they're now built to deliver a coordinated, personalized experience across the whole specialty medication journey. The conversation digs into how better technology and closer collaboration are cutting down on delays and administrative burden, so patients can start therapy sooner and stay supported once they're on treatment.  
• 
  The Medicare GLP-1 Bridge: Access, Affordability & the Pharmacist’s Role | TWIRx 04.09.2026 38λ

  TWIRx NEWS 1. Medicare Part D Paid Nearly $588 Million for Ineligible OTC Drugs   A federal audit found that Medicare Part D sponsors made approximately $587.7 million in ineligible payments from 2021 through 2023 for medications that had effectively transitioned from prescription to over-the-counter status.   The HHS Office of Inspector General cited outdated FDA information and the lack of a clear CMS rejection timeline as major contributors.   Why it matters: This exposes a serious coordination problem across FDA data, manufacturers, CMS, health plans and pharmacy claims systems.   Pharmacists may see the rejection or payment issue at the counter, but the failure often begins far upstream.   Read the Fierce Healthcare reportRead the HHS-OIG audit 2. FDA Responds to Estradiol Patch Supply Pressure   The FDA is working with six manufacturers to improve access to estradiol transdermal patches amid increased demand.   While FDA has not declared a national shortage, availability varies by product, strength and geographic area. Manufacturers are increasing production through larger batches, added shifts and expanded capacity.   Why it matters: Pharmacists are again serving as the front line of a supply-chain challenge—helping patients locate medication, coordinating with prescribers and identifying alternatives.   Read the Reuters reportRead the FDA update 3. New RSV and COVID-19 Guidance Released   The American Academy of Pediatrics and American College of Obstetricians and Gynecologists have issued updated recommendations for RSV and COVID-19 protection during the 2026–2027 respiratory season.   Why it matters: Pharmacists may face conflicting recommendations, patient confusion and questions about eligibility.   Clear counseling and coordination with pediatric and obstetric providers will be critical.   Read the Pharmacy Times report SPECIAL ANNOUNCEMENT FROM OUTCOMES   A special update from Megan Urban and Outcomes.   Outcomes is highlighting new enhancements to its Rx30 pharmacy management platform, including a refreshed user experience, automated data-entry capabilities and support from a dedicated Client Success Team.   The program will explore how these updates can streamline pharmacy workflows, save time and support greater focus on patient care.   Presented by: Dalia Rios and Kaley LesterSeptember 9, 2026 — 1:30 p.m. ET   Register here FEATURED CONVERSATION Building a Bridge to GLP-1 Access   Our featured guest is HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health.   HaVy works at the intersection of pharmacy, healthcare technology, medication affordability and prescription access.   Buzz Health operates platforms including BuzzRx, RxCompare and RxAffect, with a focus on helping connect patients, pharmacies, prescribers and prescription pricing information.   That makes today’s discussion particularly timely. THE MEDICARE GLP-1 BRIDGE   CMS launched the Medicare GLP-1 Bridge on July 1, 2026, to provide eligible Medicare Part D beneficiaries access to selected GLP-1 medications for weight management.   The demonstration runs through December 31, 2027.   Eligible beneficiaries pay $50 for a monthly supply, while the program operates outside the traditional Part D payment flow through centralized prior authorization, claims adjudication and pharmacy payment.   Eligible therapies currently include:   Foundayo®Wegovy®Zepbound®   The bigger issue is not simply GLP-1 coverage.   It is how healthcare connects eligibility, affordability, prior authorization, pharmacy workflow and patient access.   The central question for today’s discussion:   Can we create a medication-access system where patients know whether they can obtain and afford their therapy before they reach the pharmacy counter? CLOSING THOUGHT   The Medicare GLP-1 Bridge is more than another federal drug program.   It is a real-world test of how healthcare can better connect coverage, affordability, prior authorization and pharm
• 
  2026 Cencora ThoughtSpot Rewind | Part Four 03.09.2026 32λ

  Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Mike Muniz - NewRx Pharmacy Tim Weber - Good Neighbor Pharmacy Brian Pinto - Tiffany Natural Pharmacy Paul Shelton - LTC@Home Pharmacy Network Armawn Asgari - CurifyLabs
• 
  Thug Drugs: Psychedelic Studies | Pain Pod 02.09.2026 28λ

  Psychedelics, hallucinogens, natural medicines, you name it, if it has been, is, or will be in a clinical trial, we’re covering it on this episode of the Pain Pod folks! We’ll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin’ just learnin’!You’re not going to want to miss this one!Come one, come all, to the Pain Pod!!!   TzrIckmic7Yeigg0uagt
• 
  Beyond Dispensing: Building a Pharmacy Around Medication Management and Community Care | SuiteCast 01.09.2026 35λ

  Featured Guest: Bhuren Patel, CEO, PelMedsPresented by: SuiteRx Pharmacy Technology Platforms   Episode Focus This episode will explore how PelMeds has developed a closed-door, full-service pharmacy model centered on medication management, specialized packaging, compounding, specialty products, and coordinated delivery. PelMeds serves residential schools, group homes, hospice and palliative care organizations, assisted living residents, individual patients, and veterinary clients.   Discussion Topics   1. The PelMeds Growth StoryBhuren’s pharmacy leadership journey and how PelMeds evolved to meet increasingly complex medication needs.   2. Serving Diverse Care EnvironmentsThe operational differences involved in supporting group homes, assisted living communities, residential programs, hospice care, individual patients, and veterinary practices.   3. Medication Management and Specialized PackagingHow adherence packaging, refill coordination, delivery, and proactive communication improve safety, efficiency, and continuity of care.   4. Technology Behind the WorkflowHow pharmacy technology can connect dispensing, packaging, documentation, communication, delivery, and customer service.   5. Balancing Personal Service with ScaleMaintaining a high-touch pharmacy experience while expanding operations, services, and customer relationships.   Key Takeaway Successful pharmacy growth increasingly depends on combining technology, medication-management expertise, dependable delivery, and personalized service—not simply filling prescriptions.
• 
  More Patients, Same Pharmacists: Preparing Independent Pharmacy for the Next Era of MTM | Outcomes: Insights Beyond the Counter 31.08.2026 32λ

  As MTM evolves and pharmacies prepare for increased demand, what does success look like from both the technology side and the pharmacy operations side? Ross brings the perspective of innovation, workflow transformation, and MTM Intelligence. Jon brings the perspective of an independent pharmacy owner and operator who understands the realities of staffing shortages, prescription volume, patient expectations, and limited resources. The result is a conversation that feels less like a product discussion and more like an industry discussion about helping independent pharmacies thrive.   Guests: Jon Grice and Ross Frei  
• 
  Inventory, AI and Automation, R&D Tax Credits, Peptides, and Basis | The Bottom Line Rewind 29.08.2026 42λ

  Schedule an Rx AssessmentWelcome everyone to the Bottom Line Rewind, your monthly recap of the Bottom Line Pharmacy Podcast.This month, we feature interviews on topics about Inventory, AI and Automation, the Peptide PCAC meeting, R&D Tax Credits, and Basis when buying a pharmacy.Click below to check out the full episodes:Episode 1: Inventory Management in 2026 with Jared Barton, CEO of Inventory IQEpisode 2: Inside a Pharmacy AI Bot with Ross Miller, VP of Sales at TJM LabsEpisode 3: R&D Tax Credit, Trump Accounts, Taylor Swift's WeddingEpisode 4: Peptides, Policy, and PBMs with Dr. Anne West, Clinical Pharmacist at Atrium24, Dae Y. Lee, PBM & Pharmacy Practice Group Co-Chair at Buchanan Ingersoll & Rooney, P.C.Episode 5: Understanding Basis When Buying a Pharmacy with Ollin Sykes, CPA, CMA, CITPStay connected with us:Facebook | Twitter | LinkedInYouTube | TikTok | Instagram | Blog
• 
  Community Pharmacy Freedom, Cash-Based Models & AI-Powered Medication Optimization | TWIRx 28.08.2026 39λ

  Today’s episode of This Week in Pharmacy — #TWIRx is sponsored by Value Drug Company and explores two major forces reshaping pharmacy: the evolution of the community pharmacy business model and the expanding role of artificial intelligence in medication optimization and value-based care. PART ONE: The Impact of the Cash-based Community Pharmacy Special Guest: Rick Seipp, PharmD President, Value Drug CompanyCommunity pharmacy is entering a new era. In Part One, Todd Eury sits down with Rick Seipp, PharmD, President of Value Drug Company, to discuss the continued evolution and expansion of independent community pharmacy and the many different business models emerging across the profession. Independent pharmacy owners are increasingly evaluating new ways to build sustainable businesses while creating greater professional freedom for pharmacists. One of the most interesting developments is the growth of cash-based and cost-plus pharmacy models that reduce or eliminate dependence on traditional insurance reimbursement and PBM-controlled prescription economics. These models can give pharmacy owners greater control over pricing, patient relationships, clinical services and the overall direction of their businesses — while allowing pharmacists to practice with significantly less interference from insurance companies and pharmacy benefit managers. Two pharmacies in the Pittsburgh region are demonstrating how powerful this model can become:Blueberry Pharmacy — Kyle McCormick, PharmD has built Blueberry Pharmacy around a transparent, cash-based model designed to simplify prescription pricing and create a more direct relationship between the pharmacist and patient.Forward Rx Pharmacy — Brandon Antinopoulos, PharmD is another emerging example of how pharmacists can create innovative pharmacy businesses built around transparency, accessibility and freedom from many of the traditional constraints of third-party reimbursement. Todd and Rick discuss what these models mean for the broader independent pharmacy marketplace and why community pharmacy may be moving toward a much more diversified future. Sponsored by Value Drug Company, a pharmacist-led wholesale distribution partner committed to supporting the continued growth and independence of community pharmacy.https://lnkd.in/ehf76qUsPART TWO: AI-Powered Medication Optimization Special Guests:Yoona Kim, PharmD, PhDCo-Founder & CEO, ArineJenny Behan, PharmDLead Clinical Pharmacist, ArineIn Part Two, #TWIRx shifts from pharmacy business innovation to one of the most important developments occurring in clinical pharmacy: the use of artificial intelligence to optimize medication therapy at scale.Arine is an AI-powered medication optimization platform designed to improve patient outcomes and reduce healthcare costs by helping ensure patients receive the most effective and appropriate medications. Listen to This Week in Pharmacy — TWIRx on the Pharmacy Podcast Network across Apple Podcasts, Spotify, Amazon Music, iHeartRadio, YouTube and all major podcast platforms. Pharmacy Podcast Network — Amplifying the Voice of Pharmacy.
• 
  2026 Cencora ThoughtSpot Rewind | Part Three 27.08.2026 38λ

  Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Kushal Vaghani - Denbigh Pharmacy Kevin Boesen - Outcomes Gold Eneyo - Cencora Nic Bernabe - Outcomes Steven Dolan - Monroe Pharmacy Dalia Rios - Outcomes Christian Hampel - Family Prescription Counter
• 
  Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and Nutrition | MaternalRx 26.08.2026 59λ

  Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and NutritionDr. Randi Shannon said she was going to blow our minds, and she delivered!In this episode of MaternalRx, pharmacist Danielle Plummer, PharmD, sits down with Dr. Shannon, a traditional naturopath who uses Face, Tongue and Nail Analysis, an approach she describes as rooted in thousands of years of traditional medicine.Their conversation explores pregnancy preparation, nutrition, nausea and vomiting, minerals, essential oils, disease prevention, and Dr. Shannon’s belief that the face, tongue, and fingernails can reveal clues about what is happening inside the body.The interview is followed by a commentary where Danielle puts her pharmacist hat on for an evidence-based debrief, examining several of the episode’s most surprising claims and asking an essential healthcare question: What happens when an idea sounds biologically plausible, yet the clinical evidence has not been tested?Topics include Type 1 diabetes, Down syndrome, salt intake, peppermint oil in pregnancy, cholesterol, dietary oils, pharmaceuticals, nutrient requirements, and the important distinction between traditional naturopaths and licensed naturopathic doctors. This isn’t a conversation about dismissing complementary medicine. It’s about listening with curiosity while still asking important questions: What do we know? What don’t we know? Where might an approach put a patient or pregnancy at risk, and where might it support the body’s ability to heal? Stay through the end to hear Danielle's Takeaway!Section 1: Welcome and disclaimer Meet Dr. Randi Shannon What is a naturopath? Preparing the body for pregnancy Nausea in pregnancy and gut health What can fingernails tell us? Nutrients and claims about preventing or reversing disease What can the tongue reveal? What can the face reveal? Section 2: Evidence-Based Debrief Do we need exactly 60 minerals, 16 vitamins, 12 amino acids and 3 essential fatty acids? Is Type 1 diabetes created during the first trimester? Can Type 1 diabetes develop later in life? Can maternal nutrition reverse Down syndrome in utero? Peanuts, mold, aflatoxins and liver risk Peppermint essential oil during pregnancy Are Americans “undersalted”? Pharmaceuticals, synthetic drugs and side effects Cholesterol, dietary oils and reproductive health Traditional vs. licensed naturopaths Danielle’s takeaway About Dr. Randi ShannonRandi Shannon, ND, is a Florida-based traditional naturopath known for her use of Face, Tongue and Nail Analysis. She works with clients virtually in Florida, across the United States and internationally.Learn more:TheBodyCan.comRandiShannon.com/face-tongue-nail-analysis/(844) 275-1056About the HostDanielle Plummer, PharmD, is a pharmacist, antepartum doula, and founder of Obstet-Rx. Also known as HG Pharmacist, she helps women navigate Hyperemesis Gravidarum and medication use in complex pregnancies through education, advocacy and personalized medicine.HGPharmacist.comLinkedIn: linkedin.com/in/daniellerplummerHG Support Group: facebook.com/HGClinicalSolutionsImportant Listener NoteThis episode contains health and medical claims made by a guest that may differ from or contradict current evidence-based medical guidance. The guest’s statements represent her perspectives and should not be interpreted as endorsement by MaternalRx, Danielle Plummer, or the Pharmacy Podcast Network.The second half of the episode provides Danielle’s evidence-based commentary on several of these claims.This podcast is for educational purposes and is not a substitute for individualized medical care. Patients should discuss medications, supplements, herbal products, essential oils, and other treatments with an appropriately qualified healthcare professional.   TzrIckmic7Yeigg0uagt
• 
  Winning Hearts, Minds, and Policy with Strategic Communications | PBM Reform 25.08.2026 42λ

  Many pharmacy leaders focus on legislation and lobbying. Why is strategic communication on social media equally important?
• 
  Easing Prior Auth Pain Points for Specialty Pharmacies with Develop Health | NASP Specialty Pharmacy Podcast 24.08.2026 22λ

  In this episode of the NASP Podcast, host Sheila Arquette, President & CEO of NASP, speaks with Nico Kernick, Head of Growth and Operations at Develop Health. They discuss the ways AI is reducing friction and increasing transparency in the prior authorization process for providers and specialty pharmacies. Nico shares how Develop Health's AI-native workflows now support over 3 million patients, boosting submission and first-pass approval rates while keeping providers in control every step of the way. Listeners can expect to learn how pharmacies can get started overnight, plus a special offer for NASP members.
• 
  Pharmacists and Advocacy for Patients in Pain | TWIRx 21.08.2026 1ώ 9λ

  Pharmacists and Advocacy for Patients in Pain  Friday, August 21, 2026 What happens when patients living with chronic pain, their advocates, and the pharmacists responsible for dispensing opioid medications view the same healthcare system from very different perspectives? This special episode of This Week in Pharmacy brings together the Doctor Patient Forum’s founders, Claudia A. Merandi and Bev C. Schechtman, with pharmacist and nationally recognized pharmacy advocate Dr. Shane Jerominski, PharmD—better known as “The Accidental Pharmacist.” The discussion follows a wave of social-media debate surrounding Claudia’s use of the term “Harmacists,” which prompted responses from hundreds of pharmacists who felt the label misrepresented their professional responsibilities and the legal restrictions under which they practice. Rather than allow that controversy to deepen the divide, TWIRx created an opportunity for direct, respectful conversation. The purpose of this episode is to help pain-patient advocates better understand the limits pharmacists face when dispensing opioids—and to identify opportunities for pharmacists and patient organizations to advocate together for safe, compassionate and uninterrupted pain care. Five Legal and Supply-Chain Realities Affecting Opioid Dispensing Pharmacists have a federal “corresponding responsibility.”Under 21 CFR §1306.04, a controlled-substance prescription must be issued for a legitimate medical purpose. Pharmacists share legal responsibility with prescribers for determining whether a prescription is valid. Knowingly filling an illegitimate prescription may expose the pharmacist to federal penalties and professional discipline. Review the federal regulation. Schedule II prescriptions must satisfy strict requirements.Federal law generally requires a valid written or compliant electronic prescription before a Schedule II opioid may be dispensed. Emergency oral prescriptions are permitted only under limited conditions and require prescriber follow-up documentation. Schedule II opioid prescriptions cannot be refilled.Under federal law, every additional dispensing generally requires a new prescription. Partial fills are allowed only under specific circumstances, documentation requirements and time limits. Pharmacists cannot simply extend or refill opioid therapy when a patient or prescriber requests it. State laws add another layer of requirements.Depending on the state, pharmacists may have to verify prescriber authority, review prescription-monitoring information, validate electronic or security-form requirements, confirm identification, document partial fills, or comply with state-specific dispensing limitations. For example, California requires controlled-substance prescriptions to meet defined security and validity standards. California Board of Pharmacy guidance. Wholesaler monitoring can restrict a pharmacy’s opioid supply.DEA-registered distributors must identify and report suspicious controlled-substance orders under 21 CFR §1301.74. National wholesalers therefore operate monitoring programs that may delay, limit or suspend shipments based on ordering patterns, geography, drug mix and internal thresholds. These controls are imposed upstream and can leave a pharmacy unable to obtain medication—even when the pharmacist believes a prescription is clinically and legally appropriate. Review the federal distributor requirements. These examples are not exhaustive. Pharmacists must navigate overlapping federal law, DEA requirements, state pharmacy and controlled-substance laws, prescription-monitoring systems, employer policies, payer rules, wholesaler restrictions and professional standards. Requirements also vary by state and by the circumstances surrounding an individual prescription. The Central Question How can pain-patient advocates and pharmacists move beyond blame and work together to address the policies, supply restrictions, staffing conditions and regulatory pressures th
• 
  Are You Covered? A Liability Insurance Primer for Compounders | Essential: The Pharmacy Compounding Podcast 21.08.2026 30λ

  This episode looks at some smart ways to regulate pharmacy when it comes to med spas and pop-up clinics — ways that won’t cut patients off from their meds. We also look at the latest news on the thyroid-extract front, what’s happening with peptide compounding, and a bill in California that could bode well for pharmacists nationwide.Then we talk with Kristen Jones, PharmD, from Pharmacists Mutual about how insurance companies view compounding, and why compounders are taking a bigger risk than they might realize if they’re compounding peptides.Pharmacists Mutual: https://pmuw.comJoin APC: a4pc.org/joinStay up to date on these topics and more at: a4pc.org/news